# DESCRIPTION

## FIELD OF THE INVENTION

- introduce fallopian tube cells and tissues

## BACKGROUND

- motivate high-grade serous carcinoma
- limitations of current in vitro models

## SUMMARY OF THE INVENTION

- describe method for generating FTE
- specify growth factors and induction molecules
- describe method for generating FTE organoids
- describe composition of FTE organoids

## DETAILED DESCRIPTION

- define terms
- introduce background on fallopian tube epithelium (FTE)
- describe limitations of current FTE models
- introduce iPSC technology as a solution
- describe method for generating FTE from iPSCs
- detail culturing hPSCs in presence of growth factors and induction molecules
- describe generation of mesoderm cells
- detail culturing mesoderm cells in presence of growth factors and kinase inhibitors
- describe generation of intermediate mesoderm (IM) cells
- detail culturing IM cells in presence of growth factors and kinase inhibitors
- describe generation of Mullerian epithelium cells
- detail differentiating Mullerian epithelium cells into FTE
- describe method for generating FTE organoids
- detail culturing IM cells in matrix and presence of growth factors and kinase inhibitors
- describe differentiating Mullerian epithelium cells into FTE organoids
- describe composition of FTE organoids
- describe pharmaceutical composition including FTE organoids
- describe method for treating reproductive tract disease using FTE cells

### iPSC Culture

- describe iPSC culture conditions

### EXAMPLE 2

- describe directed differentiation of iPSCs into mesoderm
- describe directed differentiation of iPSCs into IM and Mullerian epithelium

### EXAMPLE 3

- describe growing FTE organoids from spheroids in Matrigel

### EXAMPLE 4

- describe RNA isolation and real-time PCR analysis

### EXAMPLE 5

- describe immunocytochemistry for monolayer culture

### EXAMPLE 6

- describe immunocytochemistry protocol for organoid and fallopian tube tissue

### EXAMPLE 7

- list primary and secondary antibodies used for fluorescence microscopy

### EXAMPLE 8

- describe fallopian tube tissue collection
- specify IRB protocol number
- describe tissue inspection and confirmation
- describe fallopian tube rinsing protocol
- describe Red Blood Cell lysis buffer composition
- describe statistical analysis software
- specify statistical analysis method
- describe data expression format
- specify significance level
- introduce mesoderm differentiation
- describe signaling pathways involved
- specify transcription factors
- describe iPSC lines used
- describe pluripotency markers
- describe differentiation into three germ layers
- describe mesoderm induction protocol
- specify activin A and CHIR99021 concentrations
- describe BRACHYURY and MIXL1 expression
- describe BMP signaling pathway
- specify BMP4 concentration
- describe PAX2, OSR1, and GATA3 expression
- describe pluripotency gene downregulation
- summarize mesoderm and IM differentiation results

